标题
Single Inhaler LABA/LAMA for COPD
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-04-25
DOI
10.3389/fphar.2019.00390
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
- (2018) Alberto Papi et al. LANCET
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
- (2018) David A. Lipson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation
- (2018) Kwun Nok Mimi Man et al. International Journal of Chronic Obstructive Pulmonary Disease
- Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial
- (2018) Peter M A Calverley et al. Lancet Respiratory Medicine
- A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD
- (2017) Chitra Lal et al. EXPERT OPINION ON PHARMACOTHERAPY
- Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
- (2017) Jørgen Vestbo et al. LANCET
- Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies
- (2017) Edward Kerwin et al. LUNG
- Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease
- (2017) Nicola A. Hanania et al. RESPIRATORY MEDICINE
- LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
- (2017) Gustavo J Rodrigo et al. International Journal of Chronic Obstructive Pulmonary Disease
- A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD
- (2016) Luigino Calzetta et al. CHEST
- Triple inhaled therapy for chronic obstructive pulmonary disease
- (2016) Paolo Montuschi et al. DRUG DISCOVERY TODAY
- A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol
- (2016) Steven J. Pascoe et al. EUROPEAN RESPIRATORY JOURNAL
- Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
- (2016) Dave Singh et al. LANCET
- Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
- (2016) Jadwiga A. Wedzicha et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
- (2016) Chris Kalberg et al. Drugs in research & development
- Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients
- (2016) Roberto W. Dal Negro et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and luticasone propionate via Accuhaler® (ENERGITO® study)
- (2016) Kai Michael Beeh et al. International Journal of Chronic Obstructive Pulmonary Disease
- Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
- (2016) Eric Derom et al. International Journal of Chronic Obstructive Pulmonary Disease
- Vilanterol trifenatate for the treatment of COPD
- (2016) Mario Malerba et al. Expert Review of Respiratory Medicine
- FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease
- (2015) Donald A. Mahler et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Bronchodilating Drugs for Chronic Obstructive Pulmonary Disease: Current Status and Future Trends
- (2015) Paolo Montuschi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside
- (2015) Mario Cazzola et al. RESPIRATORY MEDICINE
- Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations
- (2015) James F. Donohue et al. RESPIRATORY MEDICINE
- Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial
- (2015) Dave Singh et al. BMC Pulmonary Medicine
- LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD
- (2015) Santanu Sannigrahi et al. International Journal of Chronic Obstructive Pulmonary Disease
- Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data
- (2015) Joan B Soriano et al. Lancet Respiratory Medicine
- Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD
- (2014) Bartolome Celli et al. CHEST
- Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airway
- (2014) Tonio Pera et al. CURRENT OPINION IN PHARMACOLOGY
- Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping
- (2014) Paolo Montuschi et al. DRUG DISCOVERY TODAY
- Effect of Inhaler Design Variables on Paediatric Use of Dry Powder Inhalers
- (2014) Anne J. Lexmond et al. PLoS One
- Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial
- (2014) M. Reza Maleki-Yazdi et al. RESPIRATORY MEDICINE
- Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
- (2014) Dave Singh et al. BMC Pulmonary Medicine
- Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older
- (2014) Yuko Komase et al. International Journal of Chronic Obstructive Pulmonary Disease
- Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials
- (2014) Marc Decramer et al. Lancet Respiratory Medicine
- Clusters of Comorbidities Based on Validated Objective Measurements and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease
- (2013) Lowie E. G. W. Vanfleteren et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Dual bronchodilation with QVA149versussingle bronchodilator therapy: the SHINE study
- (2013) Eric D. Bateman et al. EUROPEAN RESPIRATORY JOURNAL
- Preference, satisfaction and errors with two dry powder inhalers in patients with COPD
- (2013) Job van der Palen et al. Expert Opinion on Drug Delivery
- Bronchodilator efficacy of tiotropium–formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD
- (2013) Sundeep Salvi et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
- (2013) Donald P Tashkin et al. RESPIRATORY RESEARCH
- Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD
- (2013) Henrik Svedsater et al. BMC Pulmonary Medicine
- Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study
- (2013) Marc L Decramer et al. Lancet Respiratory Medicine
- Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
- (2013) Jadwiga A Wedzicha et al. Lancet Respiratory Medicine
- Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification
- (2012) Peter Lange et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Regional quantification of muscarinic acetylcholine receptors and β-adrenoceptors in human airways
- (2012) T Ikeda et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhaler competence in asthma: Common errors, barriers to use and recommended solutions
- (2012) D. Price et al. RESPIRATORY MEDICINE
- Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison
- (2012) Donald A Mahler et al. THORAX
- Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study
- (2012) Claus F Vogelmeier et al. Lancet Respiratory Medicine
- Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
- (2011) Claus Vogelmeier et al. NEW ENGLAND JOURNAL OF MEDICINE
- The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD
- (2010) Mario Cazzola et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD
- (2010) Danilo C. Berton et al. RESPIRATORY MEDICINE
- The ADMIT series — Issues in Inhalation Therapy. 5) Inhaler selection in children with asthma
- (2010) Søren Pedersen et al. Primary Care Respiratory Journal
- Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD
- (2009) Donald P. Tashkin et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study
- (2008) Claus Vogelmeier et al. RESPIRATORY MEDICINE
- Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD
- (2007) Federico Lavorini et al. RESPIRATORY MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started